-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-09-13
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to support PCR product contamination elimination and controlled DNA repair research. It is intended for research DNA workflows, not RNA, oligonucleotides shorter than six bases, diagnostic testing, or medical use.
-
Novobiocin Sodium: Designing Better DNA Assays
2026-09-12
Novobiocin Sodium is more than an antibacterial reagent: its timed inhibition of DNA replication can expose causal links between genome duplication and bacterial morphology. This guide translates the Enterococcus faecalis protoplast study into practical assay-design and interpretation principles.
-
LNP Surface Charge and V-ATPase Drive Delivery
2026-09-12
This 2026 study proposes that lipid nanoparticle tropism is determined not only by particle surface charge but also by the V-ATPase activity of the target cell. Its in vitro and in vivo experiments connect charge-dependent delivery with endo/lysosomal function, providing a mechanistic framework for interpreting liver and lung delivery and for designing more informative trafficking assays.
-
ddhCTP: Reliable Antiviral Assay Workflows
2026-09-11
This scenario-based guide explains how ddhCTP (3ʹ-deoxy-3′,4′-didehydro-CTP), SKU B8293, can improve the interpretation and handling of RNA virus replication experiments linked to cell viability and cytotoxicity assays. It covers mechanism, controls, solution preparation, data interpretation, and practical product-selection criteria.
-
Indometacin Sodium: Assay Workflows & Optimization
2026-09-11
Indometacin Sodium Trihydrate supports reproducible COX-focused inflammation assays while also enabling oligodendrocyte differentiation and pancreatic stellate cell studies. This practical guide covers dose selection, formulation, controls, pathway interpretation, troubleshooting, and responsible compound handling.
-
DPI: From Redox Probe to Translational Strategy
2026-09-10
Diphenyleneiodonium chloride is more than a conventional NADH oxidase inhibitor: its redox activity and GPR3-linked cAMP effects make it a powerful, but context-dependent, tool for separating oxidative stress from signal transduction. This thought-leadership guide connects DPI-enabled assay design with new findings on iron, ROS, and ferroptosis in citrus immunity while defining the controls needed for translational confidence.
-
Angiotensin 1/2 (5-7): Assay Logic & Biology
2026-09-10
Angiotensin 1/2 (5-7), the H2N-Ile-His-Pro-OH peptide, is examined here as a context-dependent research tool. Learn how its molecular identity, renin-angiotensin system biology, and emerging spike–receptor evidence should shape assay design and interpretation.
-
CIP2A, PKM2, and Oxidative Phosphorylation in NSCLC
2026-09-09
The reference study identifies CIP2A as a metabolic regulator that promotes PKM2 tetramer formation, mitochondrial localization, and oxidative phosphorylation in non-small cell lung cancer. Its findings connect a specific PKM2 phosphorylation event with tumor metabolism and suggest that combining CIP2A-directed strategies with glycolysis inhibition may provide a mechanistically grounded research approach.
-
ATM Inhibition and Fenofibrate in HGSOC
2026-09-09
This study identifies a metabolic vulnerability in high-grade serous ovarian cancer (HGSOC) with intact ATM signaling. By integrating tumor-expression analyses, Dependency Map drug-sensitivity data, and cell-based validation, the authors show that ATM inhibition synergizes with fenofibrate and promotes cellular senescence, suggesting a combination strategy for HR-proficient disease.
-
Nelfinavir Mesylate: From HIV Assays to Ferroptosis
2026-09-08
Nelfinavir Mesylate is examined here as both an HIV-1 protease inhibitor and a mechanistic probe of ferroptosis-linked proteostasis. This assay-centered guide explains how to separate antiviral activity from DDI2-NFE2L1 pathway effects and select readouts that support causal interpretation.
-
IR-1061 Encapsulation in Chiral PLA Polymers
2026-09-08
The reference study shows that the enantiomeric structure of poly(lactic acid) changes how IR-1061 is accommodated, aggregated, and stabilized within a hydrophobic polymer environment. Its central practical implication is that OTN-NIR probe design should balance dye affinity, suppression of dimerization, and chemical robustness rather than selecting a carrier solely for hydrophobicity or biocompatibility.
-
TJP3, Anoikis, and Chemoresistance in Breast Cancer
2026-09-07
This study integrates anoikis-related gene profiling, machine-learning risk modeling, immune analysis, and experimental validation to identify TJP3 as a candidate driver of breast cancer chemoresistance and metastatic behavior. Its main practical contribution is a framework for linking ARG-defined tumor subgroups with prognosis, drug sensitivity, and potential immunotherapy escape, while also highlighting the need for functional validation beyond computational associations.
-
Anti Reverse Cap Analog: From Cap to Cell
2026-09-05
Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, is more than a capping reagent: it is an upstream control for interpretable synthetic mRNA experiments. This article connects orientation-specific capping with translation initiation, metabolic-protein assays, and the TCAIM–OGDH mechanism reported in Molecular Cell.
-
Adamtsl3, MMP9, and Perineuronal Net Plasticity
2026-09-05
The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal net integrity in parvalbumin-positive cortical interneurons, acting through MMP9-dependent extracellular matrix remodeling. Its genetic, morphological, biochemical, and plasticity experiments connect Adamtsl3 loss with PNN disruption, oxidative stress, altered Otx2 uptake, and the reactivation of juvenile-like adult cortical plasticity.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-04
A 2026 FASEB Journal study developed chemically modified p21 mRNA in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, disrupted cell-cycle signaling, limited tumor growth in an orthotopic mouse model, and produced predominantly bladder-localized expression with limited systemic distribution.